首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Jama cardiology

缩写:JAMA CARDIOL

ISSN:2380-6583

e-ISSN:2380-6591

IF/分区:14.1/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引2801
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Adam Ioannou,Yousuf Razvi,Aldostefano Porcari et al. Adam Ioannou et al.
Importance: Transthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive cardiomyopathy that commonly presents with concomitant chronic kidney disease. Chronic kidney dysfunction is associated with worse outcomes, but ...
Misato Chimura,Xiaowen Wang,Pardeep S Jhund et al. Misato Chimura et al.
Importance: Sex is associated with the clinical presentation, outcomes, and response to treatment in patients with heart failure (HF). However, little is known about the safety and efficacy of treatment with finerenone ac...
Ziang Yang,Xieraili Tiemuerniyazi,Fei Xu et al. Ziang Yang et al.
Importance: Efficient approaches to prevent postoperative atrial fibrillation (POAF) after coronary artery bypass grafting (CABG) are still needed. Object...
Ankeet S Bhatt,Niklas Dyrby Johansen,Muthiah Vaduganathan et al. Ankeet S Bhatt et al.
Importance: Influenza vaccination in patients with acute myocardial infarction (AMI) reduces major adverse cardiac events and is strongly recommended in clinical practice guidelines. Effective strategies to improve vaccin...
Orly Vardeny,Muthiah Vaduganathan,Brian L Claggett et al. Orly Vardeny et al.
Importance: Treatment with finerenone, a nonsteroidal mineralocorticoid receptor antagonist (MRA), improved outcomes in patients with heart failure with mildly reduced or preserved ejection fraction in FINEARTS-HF, but wa...
Mohammad Abdel Jawad,Philip G Jones,Suzanne V Arnold et al. Mohammad Abdel Jawad et al.
Importance: The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a commonly used outcome in heart failure trials. While comparing means between treatment groups improves statistical power, mean treatment effects do not ...